Scientific Reports · 2017 · 55 citations · 29 references
MedicineNuclear MedicineRadiologyBiomedical ImagingDiagnostic RadiologyMolecular ImagingInflammation ImagingNanomedicineNeutrophil BiologyPulmonary Nuclear ImagingTargeted Imaging AgentsTheranostic ImagingIn Vivo ImagingMolecular Imaging TracersMolecular Tracers For InflammationNanoparticle Imaging AgentsNanoparticle RadiotracersNanoparticle-based ProbesNanoparticle-mediated ImagingNeutrophil Imaging
Abstract In vivo detection and quantification of inflammation is a major goal in molecular imaging. Furthermore, cell-specific detection of inflammation would be a tremendous advantage in the characterization of many diseases. Here, we show how this goal can be achieved through the synergistic combination of nanotechnology and nuclear imaging. One of the most remarkable features of this hybrid approach is the possibility to tailor the pharmacokinetics of the nanomaterial-incorporated biomolecule and radionuclide. A good example of this approach is the covalent binding of a large amount of a neutrophil-specific, hydrophobic peptide on the surface of 68 Ga core-doped nanoparticles. This new nano-radiotracer has been used for non-invasive in vivo detection of acute inflammation with very high in vivo labelling efficiency, i.e. a large percentage of labelled neutrophils. Furthermore, we demonstrate that the tracer is neutrophil-specific and yields images of neutrophil recruitment of unprecedented quality. Finally, the nano-radiotracer was successfully detected in chronic inflammation in atherosclerosis-prone ApoE −/− mice after several weeks on a high-fat diet.
29
M. Amin Arnaout, Robert F. Todd, N Dana et al. · Journal of Clinical Investigation · 1983 · 301 citations · Full text